000 01511 a2200385 4500
005 20250513201421.0
264 0 _c20000201
008 200002s 0 0 eng d
022 _a1525-4135
024 7 _a10.1097/00126334-199912010-00004
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aKatzenstein, D A
245 0 0 _aDelayed-type hypersensitivity to recombinant HIV envelope glycoprotein (rgp160) after immunization with homologous antigen.
_h[electronic resource]
260 _bJournal of acquired immune deficiency syndromes (1999)
_cDec 1999
300 _a341-7 p.
_bdigital
500 _aPublication Type: Clinical Trial; Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Research Support, U.S. Gov't, P.H.S.
650 0 4 _aAIDS Vaccines
_ximmunology
650 0 4 _aHIV Envelope Protein gp160
_xadverse effects
650 0 4 _aHIV Infections
_ximmunology
650 0 4 _aHIV-1
_ximmunology
650 0 4 _aHumans
650 0 4 _aHypersensitivity, Delayed
_xetiology
650 0 4 _aLymphocyte Activation
650 0 4 _aSkin Tests
650 0 4 _aVaccination
650 0 4 _aVaccines, Synthetic
_xadverse effects
700 1 _aKundu, S
700 1 _aSpritzler, J
700 1 _aSmoller, B R
700 1 _aHaszlett, P
700 1 _aValentine, F
700 1 _aMerigan, T C
773 0 _tJournal of acquired immune deficiency syndromes (1999)
_gvol. 22
_gno. 4
_gp. 341-7
856 4 0 _uhttps://doi.org/10.1097/00126334-199912010-00004
_zAvailable from publisher's website
999 _c10589534
_d10589534